Use of VEGF inhibitors for the treatment of human cancer

Details for Australian Patent Application No. 2005254058 (hide)

Owner Regeneron Pharmaceuticals, Inc.

Inventors Cedarbaum, Jesse M.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2005254058

PCT Pub. Number WO2005/123104

Priority 60/578,499 10.06.04 US

Filing date 10 June 2005

Wipo publication date 29 December 2005

International Classifications

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

Event Publications

21 December 2006 PCT application entered the National Phase

  PCT publication WO2005/123104 Priority application(s): WO2005/123104

20 January 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005254062-High pressure spray-dry of bioactive materials

2005254057-C-purine nucleoside analogs as inhibitors of RNA-dependent RNA viral polymerase